Factor XII activation markers do not reflect FXII dependence of thrombin generation induced by polyvinylchloride

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 11, 2013, Pages 2561-2566

  Frank, Rolf Dario ^a,c   Mueller, Ute ^b   Lanzmich, Regina ^a   Floege, Jürgen ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b BMP   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COAGULATION FACTOR; COAGULATION SYSTEM; CONTACT ACTIVATION; HAEMODIALYSIS; INHIBITOR COMPLEX; LOOP MODELING; THROMBIN GENERATION; WHOLE BLOOD;

ANTIBODIES; BLOOD; COAGULATION; TUBING;

ENZYMES;

ANTIBODY; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; COMPLEMENT COMPONENT C1; POLYVINYLCHLORIDE; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; HEMODIALYSIS; HUMAN; MODEL; NORMAL HUMAN; PRIORITY JOURNAL; TUBE;

ADULT; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XII; HUMANS; POLYVINYL CHLORIDE; THROMBIN; YOUNG ADULT;

EID: 84887140102     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-5002-6     Document Type: Article

References (21)

1. Frank RD, Weber J, Dresbach H, Thelen H, Weiss C, Floege J. Role of contact activation in hemodialyzer-induced thrombogenicity. Kidney Int. 2001;60:1972-81.
2. Branger B, Garreau M, Baudin G, Gris JC. Biocompatibility of blood tubings. Int J Artif Organs. 1990;13:697-703.
3. Harmand MF, Briquet F. In vitro comparative evaluation under static conditions of the hemocompatibility of four types of tubing for cardiopulmonary bypass. Biomaterials. 1999;20:1561-71.
4. Hong J, Larsson A, Ekdahl KN, Elgue G, Larsson R, Nilsson B. Contact between a polymer and whole blood: sequence of events leading to thrombin generation. J Lab Clin Med. 2001;138:139-45.
5. Lamba NMK, Courtney JM, Gaylor JDS, Lowe GDO. In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response. Biomaterials. 2000;21:89-96.
6. Giesen PLA, Rauch U, Bohrmann B, Kling D, Roqué M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA. 1999;96:2311-5.
7. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002;8:1175-80.
8. De Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M. Inactivation of factor XII active fragment in normal plasma: predominant role of C1-inhibitor. J Clin Invest. 1984;73:1542-9.
9. Wachtfogel YT, De La Cardena RA, Colman RW. Structural biology, cellular interactions and pathophysiology of the contact system. Thromb Res. 1993;72:1-21.
10. Zhuo R, Siedlcki CA, Vogler EA. Competitive-protein adsorption in contact activation of blood factor XII. Biomaterials. 2007;28:4355-69.
11. Kaplan AP, Gruber B, Harpel PC. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay. Blood. 1985;66:636-41.
12. Ford RP, Esnouf MP, Burgess AI, Sarphie A. An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma. J Immunoassay. 1996;17:119-31.
13. Müller I, Klocke A, Alex M, Kotzsch M, Luther T, Morgenstern E, Zieseniss S, Zahler S, Preissner K, Engelmann B. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J. 2003;17:476-8.
14. Scholz T, Temmler U, Krause S, Heptinstall S, Lösche W. Transfer of tissue factor from platelets to monocytes: role of platelet-derived microvesicles and CD62P. Thromb Haemost. 2002;88:1033-8.
15. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemeron Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood. 2000;96:170-5.
16. Palmerini T, Coller BS, Cervi V, Tomasi L, Marzocchi A, Marrozzini C, Leone O, Piccioli M, Branzi A. Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. J Am Coll Cardiol. 2004;44:1570-7.
17. Sperling C, Fischer M, Maitz MF, Werner C. Blood coagulation on biomaterials requires the combination of distinct activation processes. Biomaterials. 2009;30:4447-56.
18. Salmon J, Cardigan R, Mackie I, Cohen SL, Machin S, Singer M. Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways. Intensive Care Med. 1997;23:38-43.
19. Bouman CSC, de Pont AC, Meijers J, Bakhtiari K, Roem D, Zeerleder S, Wolbink G, Korevaar JC, Levi M, de Jonge E. The effects of continuous venovenous hemofiltration on coagulation activation. Crit Care. 2006;10:R150.
20. Kohler HP, Carter AM, Stickland MH, Grant PJ. Levels of activated FXII in survivors of myocardial infarction - association with circulating risk factors and extent of coronary artery disease. Thromb Haemost. 1998;79:14-8.
21. Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Michell JP, Rosenberg RD. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation. 2000;102:2816-22.